Daniel C. Martin - Net Worth and Insider Trading

Daniel C. Martin Net Worth

The estimated net worth of Daniel C. Martin is at least $1 Million dollars as of 2024-05-05. Daniel C. Martin is the Chief Commercial Officer of Deciphera Pharmaceuticals Inc and owns about 47,660 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $1 Million. Details can be seen in Daniel C. Martin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel C. Martin has not made any transactions after 2024-01-16 and currently still holds the listed stock(s).

Transaction Summary of Daniel C. Martin

To

Daniel C. Martin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel C. Martin owns 1 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) .

Click here to see the complete history of Daniel C. Martin’s form 4 insider trades.

Insider Ownership Summary of Daniel C. Martin

Ticker Comapny Transaction Date Type of Owner
DCPH Deciphera Pharmaceuticals Inc 2024-01-16 Chief Commercial Officer

Daniel C. Martin Latest Holdings Summary

Daniel C. Martin currently owns a total of 1 stock. Daniel C. Martin owns 47,660 shares of Deciphera Pharmaceuticals Inc (DCPH) as of January 16, 2024, with a value of $1 Million.

Latest Holdings of Daniel C. Martin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DCPH Deciphera Pharmaceuticals Inc 2024-01-16 47,660 25.38 1,209,611

Holding Weightings of Daniel C. Martin


Daniel C. Martin Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel C. Martin has made a total of 11 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 1,624 shares on January 16, 2024, which brought Daniel C. Martin around $23,499.

Insider Trading History of Daniel C. Martin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel C. Martin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel C. Martin Ownership Network

Ownership Network List of Daniel C. Martin

No Data

Ownership Network Relation of Daniel C. Martin


Daniel C. Martin Owned Company Details

What does Deciphera Pharmaceuticals Inc do?

Who are the key executives at Deciphera Pharmaceuticals Inc?

Daniel C. Martin is the Chief Commercial Officer of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and SVP & Regulatory & Quality Jama Pitman .

Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary

Over the past 18 months, Daniel C. Martin made 7 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net sale of 26,559. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 14,587 shares made by Matthew L Sherman , a net sale of 11,601 shares made by Thomas Patrick Kelly , and a net sale of 7,534 shares made by Jama Pitman .

In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 154,121 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 1,687,666 shares were bought by its insiders, resulting in a net purchase of 1,533,545 shares.

Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Deciphera Pharmaceuticals Inc Insider Transactions

No Available Data

Daniel C. Martin Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel C. Martin. You might contact Daniel C. Martin via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.

Discussions on Daniel C. Martin

No discussions yet.